SCHEMBL7889347

SCHEMBL7889347

CC(C)S(=O)(=O)NC1CCc2cc(Oc3cccc(NS(C)(=O)=O)c3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 7/20 0.48
KCNH2 Q12809 4/20 0.42
PGR P06401 1/20 0.40
SLC6A4 P31645 2/20 0.37
DRD2 P14416 2/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
PIP4K2A P48426 1/20 0.37
PIP4K2B P78356 1/20 0.37
NR3C1 P04150 2/20 0.36
PDE4A P27815 3/20 0.36
PDE4B Q07343 3/20 0.36
PDE4C Q08493 3/20 0.36
PDE4D Q08499 3/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7897283 0.82 GRIA2 (0.42) GRIA2SLC6A4PDE4APDE4BPDE4C
SCHEMBL7896164 0.82 GRIA2 (0.49) GRIA2KCNH2
SCHEMBL11898789 0.81 GRIA2 (0.72) GRIA2
SCHEMBL7900759 0.81 GRIA2 (0.72) GRIA2
SCHEMBL11898573 0.81 GRIA2 (0.39) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL7896364 0.81 PDE4A (0.42) GRIA2PGRPDE4APDE4BPDE4C
SCHEMBL7899266 0.79 PDE4A (0.43) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL7899290 0.77 GRIA2 (0.42) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL4204011 0.74 PGR (0.62) PGRDRD2PIP4K2APIP4K2BNR3C1
SCHEMBL11899835 0.74 GRIA2 (0.48) GRIA2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
WO-2010115952-A1 INDANE DERIVATIVES N.V. ORGANON (NL) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202781-A1 INDANE DERIVATIVES CHRNA5, CHRNA2, GRIK5 GRIA2 24/4885KCNH2 478/4885PGR 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.